Cargando…

Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population

INTRODUCTION: In patients with hepatitis C virus (HCV), human immunodeficiency virus (HIV) represents a major cause of morbidity and economic burden. Economic evaluations in HIV-HCV typically focus on government-sponsored insurance plans rather than a commercially insured cohort. This study evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattingly, T. Joseph, Pandit, Neha S., Onukwugha, Eberechukwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522558/ https://www.ncbi.nlm.nih.gov/pubmed/30825134 http://dx.doi.org/10.1007/s40121-019-0240-7

Ejemplares similares

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses
por: Mattingly, T. Joseph, et al.
Publicado: (2020)

The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease
por: Hong, Yoon Duk, et al.
Publicado: (2020)

Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis
por: Onukwugha, Eberechukwu
Publicado: (2016)

Valuing diversity in value assessment: introducing the PhRMA Foundation Health Disparities Challenge Award
por: Onukwugha, Eberechukwu
Publicado: (2021)

Enhancing current human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C virus co-infection management
por: Huang, Zhan-Lian, et al.
Publicado: (2020)

Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast
por: Mwatelah, Ruth S., et al.
Publicado: (2015)

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
por: Marathe, Gayatri, et al.
Publicado: (2022)

Prevalence of Human Immunodeficiency Virus, Hepatitis B and Hepatitis C Virus Antibodies and Hepatitis B Antigen Among Commercial Sex Workers in Japan
por: Ishi, Kazuhisa, et al.
Publicado: (2001)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients
por: Woldemichael, Andinet, et al.
Publicado: (2016)

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage
por: Benson, Carmela, et al.
Publicado: (2020)

Cerebral Venous Thrombosis as The Sole Presenting Manifestation of Human Immunodeficiency Virus and Hepatitis B Virus Co-Infection
por: Dutta, Ajitava, et al.
Publicado: (2022)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

The Burden of Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses in Ovarian Cancer Patients in Nairobi, Kenya
por: Wanyama, Francis Mugeni, et al.
Publicado: (2022)

Why the Gap in Evaluating the Social Constructs and the Value of Medicines?
por: McRae, Jacquelyn, et al.
Publicado: (2021)

Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment
por: Shahriar, Sagarika, et al.
Publicado: (2022)

Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China
por: Chen, Weilie, et al.
Publicado: (2016)

Co-infection of hepatitis B virus and hepatitis C virus with human immunodeficiency virus infection: A cross-sectional study
por: Singh, Satyendra Kumar, et al.
Publicado: (2016)

Human immunodeficiency virus and hepatitis C virus/hepatitis B virus co-infection in Southern Brazil: clinical and epidemiological evaluation
por: Raboni, Sonia Mara, et al.
Publicado: (2014)

Corrigendum: Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C virus: prevalence, risk factors, pathogenesis, diagnosis, and treatment
por: Shahriar, Sagarika, et al.
Publicado: (2023)

Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
por: Zheng, Zhiyuan, et al.
Publicado: (2014)

Coinfection of Hepatitis B and Hepatitis C Virus in Patients With Human Immunodeficiency Virus
por: Masroor, Hassan, et al.
Publicado: (2021)

Prevalence and Risk Factors for Hepatitis C Virus Co-infection among Human Immunodeficiency Virus-Infected Patients and Effect of Hepatitis C Virus Infection on Acquired Immunodeficiency Syndrome Cases at Baseline
por: Yakubu, Abdulmumini, et al.
Publicado: (2021)

Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
por: He, Xiaoping, et al.
Publicado: (2017)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Economic Burden of Irritable Bowel Syndrome with Constipation: A Retrospective Analysis of Health Care Costs in a Commercially Insured Population
por: Doshi, Jalpa A., et al.
Publicado: (2014)

Hepatitis C testing trends among large commercially insured populations, 2011–2017
por: Khan, Mohammed A., et al.
Publicado: (2019)

Quality of life among human immunodeficiency virus-1 infected and human immunodeficiency virus-1/hepatitis C virus co-infected individuals in Iranian patients
por: Sabouri, Sarah, et al.
Publicado: (2016)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Wilson’s Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States
por: Rustgi, Vinod K., et al.
Publicado: (2021)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

Assessing uncertainty in the burden of hepatitis C virus: Comparison of estimated disease burden and treatment costs in the UK
por: Gubay, F., et al.
Publicado: (2018)

Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
por: Javadi, Abbasali, et al.
Publicado: (2014)

Biomarkers for Assessment of Human Immunodeficiency Virus and its Co-Infection with Hepatitis B and Hepatitis C Viruses: A Comprehensive Review
por: Abdi, Mohammad, et al.
Publicado: (2023)

The economic burden of Parkinson disease among Medicare beneficiaries
por: Albarmawi, Husam, et al.
Publicado: (2022)

Cost Burden of Endothelial Keratoplasty in Fuchs Endothelial Dystrophy: Real-World Analysis of a Commercially Insured US Population (2014–2019)
por: Dhaliwal, Deepinder K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nsevnb4osob40a0s84t110gdor